BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 34207137)

  • 1. Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment.
    Subhan MA; Yalamarty SSK; Filipczak N; Parveen F; Torchilin VP
    J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34207137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.
    Greish K
    J Drug Target; 2007; 15(7-8):457-64. PubMed ID: 17671892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting.
    Greish K
    Methods Mol Biol; 2010; 624():25-37. PubMed ID: 20217587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of lung cancer model characteristics on tumor targeting behavior of nanodrugs.
    Xu W; Yang S; Lu L; Xu Q; Wu S; Zhou J; Lu J; Fan X; Meng N; Ding Y; Zheng X; Lu W
    J Control Release; 2023 Feb; 354():538-553. PubMed ID: 36641120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Enhancing Blood Flow in Solid Tumor Tissue Is the Key for Achieving Satisfactory Delivery and Therapeutic Outcome of Nanodrugs via the EPR Effect.
    Wu J
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of EPR Effect and Efficacy of Anticancer Nanomedicine by Carbon Monoxide Generating Agents.
    Fang J; Islam R; Islam W; Yin H; Subr V; Etrych T; Ulbrich K; Maeda H
    Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31315251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis.
    Subhan MA; Parveen F; Filipczak N; Yalamarty SSK; Torchilin VP
    J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human solid tumors and clinical relevance of the enhanced permeation and retention effect: a 'golden gate' for nanomedicine in preclinical studies?
    Gawali P; Saraswat A; Bhide S; Gupta S; Patel K
    Nanomedicine (Lond); 2023 Jan; 18(2):169-190. PubMed ID: 37042320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H; Bharate GY; Daruwalla J
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleus-Targeting Phototherapy Nanodrugs for High-Effective Anti-Cancer Treatment.
    Long X; Zhang X; Chen Q; Liu M; Xiang Y; Yang Y; Xiao Z; Huang J; Wang X; Liu C; Nan Y; Huang Q
    Front Pharmacol; 2022; 13():905375. PubMed ID: 35645841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EPR-Effect Enhancers Strongly Potentiate Tumor-Targeted Delivery of Nanomedicines to Advanced Cancers: Further Extension to Enhancement of the Therapeutic Effect.
    Islam W; Kimura S; Islam R; Harada A; Ono K; Fang J; Niidome T; Sawa T; Maeda H
    J Pers Med; 2021 May; 11(6):. PubMed ID: 34071552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects.
    Maeda H
    Bioconjug Chem; 2010 May; 21(5):797-802. PubMed ID: 20397686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application.
    Wu J
    J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy.
    Si J; Shao S; Shen Y; Wang K
    Small; 2016 Oct; 12(37):5108-5119. PubMed ID: 27560388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS.
    Fang J; Sawa T; Maeda H
    Adv Exp Med Biol; 2003; 519():29-49. PubMed ID: 12675206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive targeting of high-grade gliomas
    Caro C; Avasthi A; Paez-Muñoz JM; Pernia Leal M; García-Martín ML
    Biomater Sci; 2021 Nov; 9(23):7984-7995. PubMed ID: 34710207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery-Personal Remarks and Future Prospects.
    Maeda H
    J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33810037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Retrospective 30 Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy--Problems, Solutions, and Prospects.
    Maeda H; Tsukigawa K; Fang J
    Microcirculation; 2016 Apr; 23(3):173-82. PubMed ID: 26237291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulating nanoparticles by EPR: A route of no return.
    Ngoune R; Peters A; von Elverfeldt D; Winkler K; Pütz G
    J Control Release; 2016 Sep; 238():58-70. PubMed ID: 27448444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro/nano-bubble-assisted ultrasound to enhance the EPR effect and potential theranostic applications.
    Duan L; Yang L; Jin J; Yang F; Liu D; Hu K; Wang Q; Yue Y; Gu N
    Theranostics; 2020; 10(2):462-483. PubMed ID: 31903132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.